|
|
|
Volumn 6, Issue 11, 2008, Pages 3-5
|
|
Existing and emerging therapeutic options for the treatment of acute myeloid leukemia.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ADENINE NUCLEOTIDE;
AMINOGLYCOSIDE;
AMONAFIDE;
ANTINEOPLASTIC AGENT;
ARABINONUCLEOSIDE;
CARBAZOLE DERIVATIVE;
CD135 ANTIGEN;
CLOFARABINE;
CYTARABINE;
DASATINIB;
DAUNORUBICIN;
DRUG DERIVATIVE;
FLT3 PROTEIN, HUMAN;
GEMTUZUMAB;
LESTAURTINIB;
MIDOSTAURIN;
MONOCLONAL ANTIBODY;
NAPHTHALIMIDE DERIVATIVE;
NONSTEROID ANTIINFLAMMATORY AGENT;
PARTHENOLIDE;
PROTEIN KINASE INHIBITOR;
PYRIMIDINE DERIVATIVE;
RETINOIC ACID;
SESQUITERPENE;
STAUROSPORINE;
THIAZOLE DERIVATIVE;
ACUTE GRANULOCYTIC LEUKEMIA;
ARTICLE;
HUMAN;
METABOLISM;
MORTALITY;
PROGNOSIS;
STEM CELL TRANSPLANTATION;
ADENINE NUCLEOTIDES;
AMINOGLYCOSIDES;
ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL;
ANTIBODIES, MONOCLONAL;
ANTINEOPLASTIC AGENTS;
ARABINONUCLEOSIDES;
CARBAZOLES;
CYTARABINE;
DAUNORUBICIN;
FMS-LIKE TYROSINE KINASE 3;
HUMANS;
LEUKEMIA, MYELOID, ACUTE;
NAPHTHALIMIDES;
PROGNOSIS;
PROTEIN KINASE INHIBITORS;
PYRIMIDINES;
SESQUITERPENES;
STAUROSPORINE;
STEM CELL TRANSPLANTATION;
THIAZOLES;
TRETINOIN;
|
|
EID: 61449104916
PISSN: 15430790
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (2)
|
|
References (0)
|
